New technology, jointly created by Case Western Reserve University and University Hospitals Cleveland Medical Center, offers a promising potential solution to women’s pelvic health disorders, including stress urinary incontinence and pelvic organ prolapse.
That technology is the basis for a medical device being developed by CollaMedix Inc. Now, the Shaker Heights, Ohio-based biotech startup has reached an exclusive licensing agreement with the Case Western Reserve Technology Transfer Office (TTO), allowing the company to secure additional funding.
Click here to read the complete article.
Story excerpt provided by Mirage News.
Originally published October 16, 2019.